Prognostic Impact of the Immunoscore Based on Whole-Slide Image Analysis of CD3+ Tumor-Infiltrating Lymphocytes in Diffuse Large B-Cell Lymphoma
Modern Pathology · 2023
DOI: 10.1016/j.modpat.2023.100224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2023. Verfasst von Bogyeong Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Pathology, Seoul National University …. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Seoul National University, Ministry of Education, Science and Technology, McJunkin Family Charitable Foundation.
Abstract (Originalsprache)
An Immunoscore based on tumor-infiltrating T-cell density was validated as a prognostic factor in patients with solid tumors. However, the potential utility of the Immunoscore in predicting the prognosis of patients with diffuse large B-cell lymphoma (DLBCL) is unclear. Here, the prognostic value of an Immunoscore based on tumor-infiltrating CD3+ T-cell density was evaluated in 104 patients with DLBCL who underwent R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) therapy. Digitally scanned whole-slide images were analyzed using Aperio ImageScope software. CD3+ cell densities in the whole tumor area were quantitated using 3 different methods, including number of CD3+ cells/area (mm2), ratio of CD3+ cells to total cells, and ratio of CD3+ cells to CD20+ cells. There was a high concordance among the 3 methods. Patients with low CD3+ cell density had an elevated serum lactate dehydrogenase level and a high Ki-67 proliferation index (all, P < .05). Patients with low CD3+ cell density, according to all 3 methods, had worse overall survival (OS) and worse progression-free survival (P < .05, all). They also had poor OS, independent of MYC/BCL2 double expression (DE) status, Eastern Cooperative Oncology Group performance status, or Ann Arbor stage (all, P < .05). These results were validated using 2 publicly available data sets. In both validation cohorts, patients with low CD3E mRNA expression had an elevated serum lactate dehydrogenase level, extranodal site involvement, and DE status (P < .05). They also had worse progression-free survival (P = .067 and P = .002, respectively) and OS (both P < .05). A low CD3E mRNA level was predictive of poor OS, independent of DE status. An Immunoscore based on whole-slide image analysis of CD3+ T-cell infiltration was sufficient to predict survival in patients with DLBCL. Low CD3+ cell density was a poor prognostic factor, independent of other prognostic parameters and DE status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Pathology, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
- Cancer Research Institute, Seoul National University, Seoul, Republic of Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Kore…
- Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Pathology, Korea University Guro Hospital, Seoul, Republic of Korea. Electronic address: sulparangi@naver.c…
- Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea; Cancer Research Institute, Seoul N…
Förderung
- Seoul National University
- Ministry of Education, Science and Technology
- McJunkin Family Charitable Foundation
Zitieren
APA
Han, B., Yim, J., Lim, S., Na, S., Lee, C., Kim, T. M., Paik, J. H., Kim, S., & Jeon, Y. K. (2023). Prognostic Impact of the Immunoscore Based on Whole-Slide Image Analysis of CD3+ Tumor-Infiltrating Lymphocytes in Diffuse Large B-Cell Lymphoma. Modern Pathology. https://doi.org/10.1016/j.modpat.2023.100224
Vancouver
Han B, Yim J, Lim S, Na S, Lee C, Kim TM, et al. Prognostic Impact of the Immunoscore Based on Whole-Slide Image Analysis of CD3+ Tumor-Infiltrating Lymphocytes in Diffuse Large B-Cell Lymphoma. Modern Pathology. 2023. doi:10.1016/j.modpat.2023.100224
BibTeX
@article{Han2023,
author = {Han, Bogyeong and Yim, Jeemin and Lim, Sojung and Na, Sei and Lee, Cheol and Kim, Tae Min and Paik, Jin-Ho and Kim, Sehui and Jeon, Yoon Kyung},
title = {Prognostic Impact of the Immunoscore Based on Whole-Slide Image Analysis of CD3+ Tumor-Infiltrating Lymphocytes in Diffuse Large B-Cell Lymphoma},
journal = {Modern Pathology},
year = {2023},
doi = {10.1016/j.modpat.2023.100224}
}
EUVIMED